HIV-negative control group HIV-positive group
  Aortic calcification score (%)  
  Total n=77 Total n=77 ≤ 0.031 n=38 >0.031 n=39 p
Age (years) 61.1 ± 6.9 47.1 ± 12.1 41.1 ± 9.9 53.0 ± 11.3 <0.0001
Male gender, n (%) 44 (57) 52 (67.5) 20 (52.6) 32 (82.1) 0.006
BMI (kg/m2) 27.0 ± 5.9 22.8 ± 4.7 23.4 ± 4.8 22.2 ± 4.7 0.307
Smoking habit, n (%) 14 (18.2) 34 (44.1) 13 (34.2) 21 (56.4) 0.053
History of CV disease, n (%) 12 (15.5) 15 (19.5) 4 (10.5) 11 (28.2) 0.046
Lipodystrophy, n (%) - 16 (20.8) 7 (18.4) 9 (23.0) 0.413
Diabetes, n (%) 3 (4) 3 (3.9) 2 (5.2) 1 (2.6) 0.500
Hypertension, n (%) 31 (41) 16 (20.8) 4 (10.5) 12 (30.8) 0.027
Systolic blood pressure (mmHg) 129.0 ± 18 125.0 ± 16.4 123.9 ± 18.7 125.9 ± 14.5 0.695
Diastolic blood pressure (mmHg) 81 ± 12 73.9 ± 10.3 71.4 ± 9.6 76.0 ± 10.6 0.131
Dyslipidemia, n (%) 26 (33.7) 26 (33.8) 8 (30.8) 18 (69.2) 0.018
Time since HIV diagnosis (years) - 9.9 ± 7.6 7.6 ± 6.7 12.0 ± 7.9 0.011
Stage A1, n (%) - 2 (2.6) 2 (5.2) 0 (0.0) 0.240
Stage A2, n (%) - 14 (18.2) 8 (21.1) 6 (15.4) 0.364
Stage A3, n (%) - 24 (31.2) 12 (31.6) 12 (30.8) 0.567
Stage B1, n (%) - 1 (1.3) 0 (0.0) 1 (2.6) 0.506
Stage B2, n (%) - 3 (3.9) 2 (5.3) 1 (2.6) 0.490
Stage B3, n (%) - 6 (7.8) 3 (7.9) 3 (7.7) 0.650
Stage C1, n (%) - 1 (1.3) 0 (0.0) 1 (2.6) 0.506
Stage C2, n (%) - 6 (7.8) 5 (13.2) 1 (2.6) 0.094
Stage C3, n (%) - 20 (26.0) 6 (15.8) 14 (35.9) 0.039
Data are expressed as mean ± SDor (for binary variables) the number (frequency).p: comparison within the HIV-positive group, as a function of the calcification score.
Abbreviations: BMI: body mass index; CV: cardioVascular.
Variables in bold type were found to be statistically significant.
Table 1: Clinical and demographic characteristics of the HIV-positiveand HIV-negative groups.
Goto home»